Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

AMERICAN ASSOCIATED PHARMACIES — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Termination

AMERICAN ASSOCIATED PHARMACIES

via FIDELIS GOVERNMENT RELATIONS

4th Quarter (Oct 1 - Dec 31) · 2020Posted Jan 18, 2021Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: AMERICAN ASSOCIATED PHARMACIES
Description: Trade association of independent pharmacies
Location: Alabama · United States of America

Registrant

Firm: FIDELIS GOVERNMENT RELATIONS
Description: Government relations consulting firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Pharmacy benefit manager issues pharmacist provider status issues
LobbyistsTERRY ALLEN · WAYNE KING
Covered position (TERRY ALLEN): Chief of Staff, Rep. Steve Largent
Covered position (WAYNE KING): Deputy Chief of Staff, Rep. Mark Meadows
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.